Pathology of the gallbladder: A concise review

Current Diagnostic Pathology

Volumn 10, Issue 4, 2004, Pages 304-317

  Hansel, D E ^a   Maitra, A ^a   Argani, P ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adenocarcinoma; Dysplasia; Gallbladder; Grade; Histology; Metaplasia; Mutation; Stage

Indexed keywords

ADENOCARCINOMA; ADENOMA; BILE DUCT CYST; CARCINOSARCOMA; CHRONIC CHOLECYSTITIS; CLEAR CELL CARCINOMA; COLON; CYSTADENOMA; DYSPLASIA; EOSINOPHIL; FOAM CELL; GALLBLADDER; GALLBLADDER CANCER; GALLBLADDER CARCINOMA; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; INFLAMMATION; LYMPHOCYTE; METASTASIS; MUCINOUS CARCINOMA; NEOPLASM; PAPILLARY CARCINOMA; PLASMA CELL; REVIEW; SMALL CELL CARCINOMA; SQUAMOUS CELL CARCINOMA; SQUAMOUS CELL METAPLASIA; UNDIFFERENTIATED CARCINOMA;

EID: 3042718664     PISSN: 09686053     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cdip.2004.03.006     Document Type: Article

References (52)

1. Albores-Saavedra J, Henson DE, Klimstra DS. Tumors of the gallbladder, extrahepatic bile ducts, and ampulla of Vater. In: Atlas of Tumor Pathology. Armed Forces Institute of Pathology. Third Series, Fascicle #27.
2. Ashur H., Siegal B., Oland Y., Adam Y.G. Calcified gallbladder (porcelain gallbladder). Arch Surg. 113:1978;594-596
3. Dabbs D.J. Eosinophilic and lymphoeosinophilic cholecystitis. Am J Surg Pathol. 17:1993;497-501
4. Jesserun J., Bolio-Solis A., Manivel J.C. Diffuse lymphoplasmacytic acalculus cholecystitis. a distinctive form of chronic cholecystitis associated with primary sclerosing cholangitis Hum Pathol. 28:1998;512-517
5. Abraham S.C., Cruz-Correa M., Argani P., et al. Lymphoplasmacytic chronic cholecystitis and biliary tract disease in patients with lymphoplasmacytic sclerosing pancreatitis. Am J Surg Pathol. 27:2003;441-451
6. Abraham S.C., Cruz-Correa M., Argani P., et al. Diffuse lymphoplasmacytic chronic cholecystitis is highly specific for extrahepatic biliary tract disease but does not distinguish between primary and secondary sclerosing cholangiopathy. Am J Surg Pathol. 27:2003;1313-1320
7. Duarte I., Llanos O., Domke H., et al. Metaplasia and precursor lesions of gallbladder carcinoma. Cancer. 72:1993;1878-1884
8. Wistuba I.I., Sugio K., Hung J., et al. Allele-specific mutations involved in the pathogenesis of endemic gallbladder carcinoma in Chile. Cancer Res. 55:1995;2511-2515
9. Hansel D.E., Meeker A.K., Hicks J., et al. Telomere length variation in biliary tract metaplasia, dysplasia, and carcinoma. Modern Pathol. 16:2003;120A-121A
10. Meeker A.K., Hicks J.L., Argani P., et al. Direct evidence of telomere shortening in a wide range of human epithelial pre-cancerous lesions. Mod Pathol. 16:2003;298A
11. Wistuba I.I., Miguel J.F., Gazdar A.F., Albores-Saavedra J. Gallbladder adenomas have molecular abnormalities different from those present in gallbladder carcinomas. Hum Pathol. 30:1999;21-23
12. Chang H.J., Jee C.D., Kim W.H. Mutation and altered expression of β-catenin during gallbladder carcinogenesis. Am J Surg Pathol. 26:2002;758-766
13. Yanagisawa N., Mikami T., Saegusa M., Okayasu I. More frequent β-catenin exon 3 mutations in gallbladder adenomas than in carcinomas indicate different lineages. Cancer Res. 61:2001;19-22
14. Rashid A., Gao Y-.T., Bhakta S., et al. β-catenin mutations in biliary cancers. a population based study in China Cancer Res. 61:2001;3406-3409
15. Albores-Saavedra J., Nadji M., Morales A.R., Henson D.E. Carcinembryonic antigen in normal, preneoplastic and neoplastic gallbladder epithelium. Cancer. 52:1983;1069-1072
16. Maxwell P., Davis R.I., Sloan J.M. Carcinoembryonic antigen (CEA) in benign and malignant epithelium of the gall bladder, extrahepatic bile ducts, and ampulla of Vater. J Pathol. 170:1993;73-76
17. Wistuba I.I., Gazdar A.F., Roa I., Albores-Saavedra J. P53 protein overexpression in gallbladder carcinoma and its precursor lesions. an immunohistochemical study Hum Pathol. 27:1996;360-365
18. Parwani A., Geradts J., Caspers E., et al. Immunohistochemical and genetic analysis of non-small cell and small cell gallbladder carcinoma and their precursor lesions. Mod Pathol. 16:2003;299-308
19. Lazcano-Ponce E.C., Miquel J.F., Munoz N., et al. Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J Clin. 51:2001;349-364
20. De Groen P.C., Gores G.J., LaRusso N.F., et al. Biliary tract cancers. NEJM. 341:1999;1368-1378
21. Hanada K., Itoh M., Fujii K., et al. K-ras and p53 mutations in stage 1 gallbladder carcinoma with an anomalous junction of the pancreaticobiliary duct. Cancer. 77:1996;452-458
22. Pradeep R., Kaushik S.P., Sikora S.S., et al. Predictors of survival in patients with carcinoma of the gallbladder. Cancer. 76:1995;1145-1149
23. American Joint Committee on Cancer Cancer staging handbook, 6th edition. New York: Springer, 2002. p. 155-61.
24. Hamilton S.R., Aaltonon L.A. Pathology and genetics. Tumours of the digestive system. WHO Classification of Tumors. 2000;IARC Press, Lyon, France
25. Vardaman C., Albores-Saavedra J. Clear cell carcinomas of the gallbladder and extrahepatic bile ducts. Am J Surg Pathol. 19:1995;91-99
26. Maitra A., Tascilar M., Hruban R.H., et al. Small cell carcinoma of the gallbladder. A clinicopathologic, immunohistochemical, and molecular pathology study of 12 cases. Am J Surg Pathol. 25:2001;595-601
27. Sinkre P.A., Murakata L., Rabin L., et al. Clear cell carcinoid of the gallbladder. Am J Surg Pathol. 25:2001;1334-1339
28. Papotti M., Cassoni P., Sapino A., et al. Large cell neuroendocrine carcinoma of the gallbladder. Am J Surg Pathol. 24:2000;1424-1428
29. Devaney K., Goodman Z.D., Ishak K.G. Hepatobiliary cystadenoma and cystadenocarcinoma. A light microscopic and immunohistochemical study of 70 patients. Am J Surg Pathol. 18:1994;1078-1091
30. Donahue J.H., Nagorney D.M., Grant C.S., et al. Carcinoma of the gallbladder. Does radical resection improve outcome? Arch Surg. 125:1990;237-241
31. Nakamura S., Nishiyama R., Yokoi Y., et al. Hepatopancreatoduodenectomy for advanced gallbladder carcinoma. Arch Surg. 129:1994;625-629
32. Nakamura S., Sakaguchi S., Suzuki S., Muro H. Aggressive surgery for carcinoma of the gallbladder. Surgery. 106:1989;467-473
33. Giatromanolaki A., Sivridis E., Koukourakis M.I., et al. Prognostic role of angiogenesis in operable carcinoma of the gallbladder. Am J Clin Oncol. 25:2002;38-41
34. Yamaguchi R., Nagino M., Oda K., et al. Perineural invasion has a negative impact on survival of patients with gallbladder carcinoma. Br J Surg. 89:2002;1130-1136
35. Kim S.W., Her K-.H., Jang J-.Y., et al. K-ras oncogene mutation in cancer and precancerous lesions of the gallbladder. J Surg Oncol. 75:2000;246-251
36. Wistuba I.I., Tang M., Maitra A., et al. Genome-wide allelotyping analysis reveals multiple sites of allelic loss in gallbladder carcinoma. Cancer Res. 61:2001;3795-3800
37. Wistuba I.I., Maitra A., Carrasco R., et al. High resolution chromosome 3p, 8p, 9q, and 22q allelotyping analysis in the pathogenesis of gallbladder carcinoma. Br J Cancer. 87:2002;432-440
38. Wistuba I.I., Ashfaq R., Maitra A., et al. Fragile histidine triad gene abnormalities in the pathogenesis of gallbladder carcinoma. Am J Pathol. 160:2002;2073-2079
39. Suzuki T., Takano Y., Kakita A., Okudaira M. An immunohistochemical and molecular biological study of c-erb-2 amplification and prognostic relevance in gallbladder cancer. Pathol Res Pract. 189:1993;283-292
40. Rashid A., Ueki T., Gao Y-.T., et al. K-ras mutation, p53 overexpression, and microsatellite instability in biliary tract cancers. a population-based study in China Clin Cancer Res. 8:2002;3156-3163
41. House M.G., Wistuba I.I., Argani P., et al. Progression of methylation in gallstone disease leading to gallbladder cancer. Ann Surg Oncol. 10:2003;882-889
42. Hansel D.E., Rahman A., Hidalgo M., et al. Identification of novel cellular targets in biliary tract cancers using global gene expression technology. Am J Pathol. 163:2003;217-219
43. Hanada K., Itoh M., Fujii K., et al. TP53 mutations in stage 1 gallbladder carcinoma with special attention to growth patterns. Eur J Cancer. 33:1997;1136-1140
44. Itoi T., Watanabe H., Ajioka Y., et al. APC, K-ras codon 12 mutation and p53 gene expression in carcinoma and adenoma of the gallbladder suggest two genetic pathways to gallbladder carcinogenesis. Pathol Int. 46:1996;333-340
45. Ink4B/MST2 genes in biliary tract cancers. Cancer Res. 55:1995;2756-2760
46. Takagi S., Naito E., Yamanouchi H., et al. Mutation of the p53 gene in gallbladder cancer. Tohoku J Exp Med. 172:1994;283-289
47. Kim Y-.T., Kim J., Jang Y.H., et al. Genetic alterations in gallbladder adenoma, dysplasia, and carcinoma. Cancer Lett. 169:2001;59-68
48. Kim Y.W., Huh S.H., Park Y.K., et al. Expression of the c-erb-B2 and p53 protein in gallbladder carcinomas. Oncol Rep. 8:2001;1127-1132
49. Ajiki T., Onoyama H., Yamamoto M., et al. P53 protein expression and prognosis in gallbladder carcinoma and premalignant lesions. Hepatogastroenterology. 43:1996;521-526
50. Ajiki T., Fujimori T., Onoyama H., et al. K-ras gene mutation in gall bladder carcinomas and dysplasia. Gut. 38:1996;426-429
51. Yoshida T., Sugai T., Habano W., et al. Microsatellite instability in gallbladder carcinoma. two independent genetic pathways of gallbladder carcinogenesis J Gastroenterol. 35:2000;768-774
52. Kamel D., Paakko P., Nuorva K., et al. P53 and c-erb-2 protein expression in adenocarcinoma and epithelial dysplasias of the gallbladder. J Pathol. 170:1993;67-72